# Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice

> **NCT01106118** · — · COMPLETED · sponsor: **Bayer** · enrollment: 2289 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** Vardenafil (Levitra, BAY38-9456)

## Key facts

- **NCT ID:** NCT01106118
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01
- **Primary completion:** 2012-12
- **Final completion:** 2013-08
- **Target enrollment:** 2289 (ACTUAL)
- **Last updated:** 2016-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01106118

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01106118, "Therapeutic Effectiveness of Vardenafil in Patients With Erectile Dysfunction and Metabolic Syndrome in Daily Clinical Practice". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01106118. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*